HYAMIRA SIR INTRA-ART 2% 40MG

 

Deficiency of the superficial papillary dermis, correction of the contours of soft tissue such as acne scars and scars in general, restoration of tissue trophism.

Hyamira is a medical device with CE marking compliant with the MDD 93/42/EEC directive and subsequent amendments and additions, containing hyaluronic acid obtained by fermentation and not chemically modified. Hyamira is a physiological, transparent, sterile, apyrogenic and viscoelastic solution supplied in a pre-filled glass syringe containing hyaluronic acid in volumes of 1 or 2 ml, packaged in a blister. The content of the syringe is sterilized with moist heat. Hyaluronic acid is a natural polysaccharide present in the extracellular matrix of the skin and has the function of regulating hydration and elasticity. To counteract the effects exerted on the skin by aging and lifestyle-related factors such as smoking or sun exposure, the administration of hyaluronic acid through intradermal injections results in an improvement in skin firmness and elasticity.

Mode of use
Remove the protective cap of the syringe taking special care to avoid contact with the opening. Firmly screw a needle with a diameter of 30 - 32 G onto the closure collar of the Luer type to ensure a tight seal. Before injection, treat the site with an appropriate antiseptic solution. Inject Hyamira intradermally at a medium, medium-deep level of the dermis; small wrinkles can be treated with superficial implants using either linear or micro-bump techniques. For the treatment of large areas, the matrix technique or crossed linear technique is recommended. After the injection, gently massage the treated area for better product distribution. Hyamira can be used for the treatment of various regions such as the face, neck, hands, and décolleté. It is advisable to carry out personalized treatment programs based on the patient’s needs.

Components
Sodium hyaluronate, sodium chloride, sodium phosphate, and water for injection (as needed).

Warnings
- The content of the pre-filled syringe is sterile. The syringe is packaged in a sealed blister. The external surface of the syringe is not sterile.
- Do not use Hyamira after the expiration date on the packaging.
- Do not use Hyamira if the packaging or syringe are opened or damaged.
- The injection site must be on healthy skin.
- Do not inject in areas where inflammatory processes are present.
- Do not inject vascularly, into muscles, tendons, or for breast augmentation.
- Do not mix with other products.
- Hyamira has not been tested in pregnant or breastfeeding women.
- Hyamira is for single use only and should not be re-sterilized.
- Once the package is opened, Hyamira must be used immediately and disposed of after use in accordance with current regulations.
- Keep out of reach of children.
- After the injection and in the following 3-5 days, advise the patient to avoid exposure to UV rays and to protect the treated areas with full protection sunscreens.

Hyamira should not be administered:
- to patients with known sensitivity to hyaluronic acid and its related compounds
- in the case of infection or skin disease near the injection site.
Some transient side reactions may occur following the injection of Hyamira, such as swelling, erythema, or redness. Such secondary manifestations can be alleviated with the application of ice to the treated area. Normally, these disappear within a few hours after implantation. The doctor must ensure that patients inform him of any adverse effects that occur after treatment.

Storage
Store at a temperature between 0°C and 25°C, protected from direct sunlight and frost.
Shelf life of the unopened package: 36 months.

Format
Package of 1 pre-filled syringe available in the following concentrations:
- 1.6% (16 mg/1 ml and 32 mg/2 ml)
- 2.0% (20 mg/1 ml and 40 mg/2 ml)

Code
H16001 H16002 H20001 H200002.